Glucocorticoid Receptor Antibody for Flow Cytometry

Flow Cytometry (1-2 ug/test), Gel Shift (Assay dependent), Immunocytochemistry (Assay dependent), Immunofluorescence (1:50-1:500), Immunohistochemistry (Paraffin) (5 µg/ml), Immunohistochemistry (PFA fixed) (1/500), Immunoprecipitation (Assay dependent), Western Blot (5 µg/ml)

Nuclear receptor subfamily 3 group C member 1

Flow Cytometry (1/200-1/400), Immunocytochemistry (1:200-1:1000), Immunofluorescence (1/200-1/1000), Immunohistochemistry (1/200-1/1000), Western Blot (1/500-1/2000)

Nuclear receptor subfamily 3 group C member 1

Flow Cytometry (Neat- 1/10)

Nuclear receptor subfamily 3 group C member 1

Flow Cytometry (3-5 µg x 10^6 cells), Gel Shift (Assay Dependent), Immunofluorescence (10 µg/ml), Immunoprecipitation (Assay dependent), Western Blot (1 µg/ml)

Nuclear receptor subfamily 3 group C member 3

Flow Cytometry (3-5 µg x 10^6 cells), Immunocytochemistry (2µg/ml), Immunofluorescence (2µg/ml), Western Blot (2 ug/ml)

Nuclear receptor subfamily 3 group C member 4; Dihydrotestosterone receptor

Flow Cytometry (1:10-1:50), Immunocytochemistry (1:10-1:50), Immunofluorescence (1:10-1:50), Western Blot (1:1000)

CRT, CT-R, CTR, CTR1

Flow Cytometry (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

Leukocyte receptor cluster member 7; Eukaryotic elongation factor 1 A-1; Elongation factor Tu

Flow Cytometry (1:10-1:50), Immunocytochemistry (1:10-1:50), Immunofluorescence (1:10-1:50), Immunohistochemistry (1:10-1:50), Western Blot (1:1000)

Leukocyte receptor cluster member 7; Eukaryotic elongation factor 1 A-1; Elongation factor Tu

Flow Cytometry (3-5 µg/million cells), Western Blot (1-3 ug/ml)

CD220, HHF5, insulin receptor, INSR, CD221, IGF-I receptor, insulin-like growth factor I receptor, soluble IGF1R variant 1, soluble IGF1R variant 2

Flow Cytometry (1:100-1:500), Immunocytochemistry (1:100-1:500), Immunofluorescence (1:100-1:500), Immunohistochemistry (Assay Dependent), Western Blot (Assay Dependent)

Insulin-like growth factor I receptor

Affinity Purification (Assay Dependent), ELISA (Assay Dependent), Flow Cytometry (2 ug/test), Immunocytochemistry (1:10-1:100), Immunofluorescence (1:10-1:100), Immunoprecipitation (2 µg/ml), Western Blot (1-3 µg/ml)

CD220, CD220 beta, HHF5, IR beta

ELISA (Assay Dependent), Flow Cytometry (Assay-Dependent), Functional Assay (Assay Dependent), Immunocytochemistry (1:10-1:100), Immunofluorescence (Assay-Dependent), Immunohistochemistry (Frozen) (2-4µg/ml), Immunohistochemistry (Paraffin) (Assay-Dependent), Western Blot (Assay Dependent)

CD220, CD220 beta, HHF5, IR beta

Flow Cytometry (Assay Dependent)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (Assay Dependent)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (2-10 ug/ml), Functional Assay (Assay-Dependent)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (Assay Dependent), Immunohistochemistry (Paraffin) (Assay-Dependent)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

ChIP assay (5µl per 10^6 cells), Flow Cytometry (1µg per 10^6 cells), Immunohistochemistry (Paraffin) (1:200), Immunoprecipitation (Assay dependent), Western Blot (1:500-1:5000)

Steroid receptor coactivator 1; Renal carcinoma antigen NY-REN-52; RIP160; Protein Hin-2; Class E basic helix-loop-helix protein 74; Nuclear receptor coactivator protein 1

Flow Cytometry (3-5 µg x 10^6 cells), Immunocytochemistry (1-2 µg/ml), Immunofluorescence (1-2 µg/ml), Immunohistochemistry (Frozen) (1 µg/ml), Western Blot (1 µg/ml)

Steroid receptor coactivator 1; Renal carcinoma antigen NY-REN-52; RIP160; Protein Hin-2; Class E basic helix-loop-helix protein 74; Nuclear receptor coactivator protein 1

Flow Cytometry (10 µl/10^6 cells)

Tyrosine-protein kinase receptor flk-2; Fms-like tyrosine kinase 3; Fetal liver kinase 2; FL cytokine receptor

Flow Cytometry (10 µl/10^6 cells)

Tyrosine-protein kinase receptor flk-2; Fms-like tyrosine kinase 3; Fetal liver kinase 2; FL cytokine receptor

Flow Cytometry (1:10-1:50), Immunohistochemistry (1:50-1:100), Western Blot (1:1000)

Stem cell tyrosine kinase 1; Fms-like tyrosine kinase 3; Fetal liver kinase-2; FL cytokine receptor

Blocking Assay (Assay-Dependent), Flow Cytometry (2.5 µg/10^6 cells), Immunohistochemistry (Paraffin) (5-15 µg/ml), Western Blot (0.1 µg/ml)

Glucocorticoid-induced TNFR-related protein; Activation-inducible TNFR family receptor

Flow Cytometry (10 ul/10^6 cells)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (1:200-1:400), Immunocytochemistry (1:200-1:1000), Immunofluorescence (1:200-1:1000), Western Blot (1:500-1:2000)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (Assay Dependent)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (Assay Dependent)

FASLG receptor; Apoptosis-mediating surface antigen FAS; Apo-1 antigen

Flow Cytometry (1 ug/1 million cells), Immunohistochemistry (Frozen) (Assay Dependent)

Glucocorticoid-induced TNFR-related protein

ChIP assay (1:100), Flow Cytometry (1:50), Gel Shift (Assay dependent), Immunocytochemistry (Assay dependent), Immunofluorescence (1:10-1:100), Immunohistochemistry (Frozen) (Assay dependent), Immunoprecipitation (Assay dependent), Western Blot (1:500-1:2000)

Class E basic helix-loop-helix protein 76

Flow Cytometry (0.5-2 µg/10^6 cells), Immunocytochemistry (1:10-1:500), Immunofluorescence (1:10-1:500), Immunohistochemistry (Frozen) (1:500), Immunohistochemistry (Paraffin) (5 µg/ml), Western Blot (1-3 µg/ml)

hToll

Flow Cytometry (1/100), Immunocytochemistry (1:200-1:2000), Immunofluorescence (1:200-1:2000), Immunohistochemistry (1:1000), Immunohistochemistry (Paraffin) (Assay Dependent), Immunoprecipitation (Assay dependent), Western Blot (1:1,000)

Telomerase-binding protein p23; Progesterone receptor complex p23; Hsp90 co-chaperone; Cytosolic prostaglandin E2 synthase